- Home
- STKS vs NKTR Comparison
STKS vs NKTR Comparison
Compare STKS & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKS
- NKTR
- Stock Information
- Founded
- STKS 2004
- NKTR 1990
- Country
- STKS United States
- NKTR United States
- Employees
- STKS N/A
- NKTR N/A
- Industry
- STKS Restaurants
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- STKS Consumer Discretionary
- NKTR Health Care
- Exchange
- STKS Nasdaq
- NKTR Nasdaq
- Market Cap
- STKS 112.2M
- NKTR 125.5M
- IPO Year
- STKS N/A
- NKTR 1994
- Fundamental
- Price
- STKS $3.43
- NKTR $8.51
- Analyst Decision
- STKS Buy
- NKTR Strong Buy
- Analyst Count
- STKS 2
- NKTR 6
- Target Price
- STKS $4.25
- NKTR $73.75
- AVG Volume (30 Days)
- STKS 58.7K
- NKTR 348.5K
- Earning Date
- STKS 08-05-2025
- NKTR 08-07-2025
- Dividend Yield
- STKS N/A
- NKTR N/A
- EPS Growth
- STKS N/A
- NKTR N/A
- EPS
- STKS N/A
- NKTR N/A
- Revenue
- STKS $799,478,000.00
- NKTR $87,248,000.00
- Revenue This Year
- STKS $28.67
- NKTR N/A
- Revenue Next Year
- STKS $5.12
- NKTR N/A
- P/E Ratio
- STKS N/A
- NKTR N/A
- Revenue Growth
- STKS 138.50
- NKTR N/A
- 52 Week Low
- STKS $2.37
- NKTR $6.48
- 52 Week High
- STKS $5.42
- NKTR $22.79
- Technical
- Relative Strength Index (RSI)
- STKS 46.52
- NKTR 42.19
- Support Level
- STKS $3.35
- NKTR $7.99
- Resistance Level
- STKS $3.80
- NKTR $9.71
- Average True Range (ATR)
- STKS 0.29
- NKTR 1.37
- MACD
- STKS -0.04
- NKTR -0.20
- Stochastic Oscillator
- STKS 34.57
- NKTR 11.66
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.